Related Experiment Video

Updated: May 25, 2026

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
07:39

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Published on: June 28, 2019

Cancer cell senescence: a new frontier in drug development

Claire J Cairney1, Alan E Bilsland, T R Jeffry Evans

  • 1Institute of Cancer Sciences, University of Glasgow, CRUK Beatson Laboratories, Bearsden, Glasgow, UK.

Drug Discovery Today
|February 9, 2012
PubMed

Insights

Cellular senescence universally blocks cancer development, presenting a promising therapeutic target. This review explores strategies for developing senescence-inducing drugs and biomarkers for cancer treatment.

Area of Science:

  • Oncology
  • Cell Biology
  • Pharmacology

Background:

  • Cellular senescence acts as a natural barrier against cancer initiation and progression.
  • Senescence impacts all key hallmarks of cancer, highlighting its therapeutic potential.
  • Targeting senescence offers a novel strategy for cancer drug discovery.

Purpose of the Study:

  • To review progress in targeting cellular senescence for cancer therapy.
  • To discuss promising approaches for discovering senescence-inducing drugs and biomarkers.
  • To explore the clinical application of senescence-induction therapy.

Main Methods:

  • Literature review of recent advancements in senescence research.
  • Analysis of strategies for drug and biomarker discovery related to senescence.
  • Discussion of clinical translation of senescence-targeting therapies.

Main Results:

  • Senescence is a validated anti-cancer mechanism with broad implications.
  • Challenges remain in identifying robust senescence inducers and biomarkers.
  • Promising avenues for drug and biomarker development are emerging.

Conclusions:

  • Translating senescence into effective cancer therapies requires focused drug and biomarker discovery programs.
  • Senescence-induction therapy holds potential for clinical application in cancer treatment.
  • Further research is needed to overcome current challenges and optimize therapeutic strategies.

More Related Videos

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells08:56

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells

Published on: July 12, 2022

A Sensitive Method to Quantify Senescent Cancer Cells09:18

A Sensitive Method to Quantify Senescent Cancer Cells

Published on: August 2, 2013

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...